SEC Form 4 · accession 0001493152-15-000899
LIXTE BIOTECHNOLOGY HOLDINGS, INC. · NMAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John S Kovach
Officer — President · Director · 10% Owner
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 17, 2015 | J | 92,717 | $1.00 | A | 17,121,503 | D |
Table II — derivative securities
No Table II lines on this filing.